Pharmaceutical - Financial, Markets & Marketing

Filter

Popular Filters

1 to 25 of 96 results

MNPCs face protectionist hurdles as Turkey lays plans to become a net pharma exporter

MNPCs face protectionist hurdles as Turkey lays plans to become a net pharma exporter

18-07-2014

Turkey continues to hold appeal for multinational pharmaceutical companies (MNPCs) due to its large domestic…

FinancialHealth Medical PharmaMarkets & MarketingPharmaceuticalPharmaceutical export industryPharmaceutical sciencesPharmaceuticals policyPharmacologyPricingTurkey

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

05-06-2014

UK pharma giant GlaxoSmithKline has agreed to a $105 million settlement with 44 US states and the District…

AdvairFinancialGlaxoSmithKlineLegalMarkets & MarketingNeurologicalPaxilPharmaceuticalRespiratory and PulmonaryUSAWellbutrin

Joint position to grow Australia's biopharmaceutical industry

Joint position to grow Australia's biopharmaceutical industry

29-05-2014

Trade groups AusBiotech and Medicines Australia this morning published a joint statement sent to the…

AustraliaBiotechnologyFinancialMarkets & MarketingPatentsPharmaceuticalResearch

US state is at ‘crossroads’ for life sciences research, report finds

US state is at ‘crossroads’ for life sciences research, report finds

27-05-2014

The US state of Massachusetts has a thriving life sciences industry but is at a crossroads, according…

Biopharma value chainFinancialHealthHealth Medical PharmaMarkets & MarketingMedicinePharmaceuticalProfessorUSA

Growth strategy for Greek pharma industry

19-05-2014

An action plan to unlock the huge potential of the pharmaceutical industry in Greece and underscore its…

FinancialGreeceMarkets & MarketingPharmaceuticalResearch

Ukraine drug imports halted due to VAT confusion

Ukraine drug imports halted due to VAT confusion

15-04-2014

Imports of medicines into Ukraine have completely stopped, due to current confusions regarding the value-added…

Eastern EuropeFinancialMarkets & MarketingPharmaceuticalUkraine

Total spending growth returns for US medicines, reports IMS Health

Total spending growth returns for US medicines, reports IMS Health

15-04-2014

Total spending on US medicines increased 1.0% on a real per capita basis in 2013, while the use of health…

FinancialHealthcareMarkets & MarketingNorth AmericaPharmaceuticalUSA

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU

10-04-2014

The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

Philippine government increasing financial support for health care spending

28-03-2014

The size of the Philippine pharmaceutical market, now worth around $3.2 billion, is expected to expand…

Asia-PacificFinancialGenericsMarkets & MarketingPharmaceutical

Generic drugs slow pharma spending growth in Canada

Generic drugs slow pharma spending growth in Canada

13-03-2014

Last year, C$29.3 billion ($26.47 billion) was spent on prescription drugs in Canada, but the annual…

CanadaFinancialGenericsMarkets & MarketingNorth AmericaPharmaceutical

Endo agrees $193 million settlement with US Justice Dept over Lidoderm

23-02-2014

US drugmaker Endo Health Solutions and its subsidiary Endo Pharmaceuticals have agreed to pay $192.7…

Endo Health SolutionsFinancialLegalLidodermMarkets & MarketingNeurologicalPharmaceutical

Report: IPOs and government support can boost the Australian life sciences industry

Report: IPOs and government support can boost the Australian life sciences industry

18-02-2014

Despite a relatively flat December quarter for the PricewaterhouseCoopers Life Sciences Index, it was…

AustraliaBiotechnologyCSL LimitedFinancialMarkets & MarketingPharmaceutical

Five big pharma firms named as high performers in annual biopharmaceutical report

Five big pharma firms named as high performers in annual biopharmaceutical report

12-02-2014

Entry in emerging markets and expedient product launches are still driving the pharma market, according…

AmgenAstellas PharmaBristol-Myers SquibbFinancialMarkets & MarketingNovo NordiskPharmaceuticalResearchRoche

Investment opportunities in Central & Eastern Europe pharmaceuticals

22-01-2014

Business Monitor has just released its latest analysis on the Central and Eastern European Pharmaceuticals…

Czech RepublicEastern EuropeFinancialHealthcareMarkets & MarketingPharmaceuticalRussia

New schizophrenia drug Abilify to lead the market by 2016

New schizophrenia drug Abilify to lead the market by 2016

29-12-2013

Long-acting depot therapy Abilify Maintena (aripiprazole) will become the leading injectable schizophrenia…

AbilifyAbilify MaintenaFinancialGlobalLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceutical

Report: Spain’s pharmaceutical spending decline is hitting R&D

28-12-2013

Data from Spain’s Ministry of Health, Social Services and Equality has reported a decline in pharmaceutical…

FinancialMarkets & MarketingNorthern EuropePharmaceutical

Report: Alzheimer’s Disease market to reach $3.8 billion in 2019

Report: Alzheimer’s Disease market to reach $3.8 billion in 2019

27-12-2013

The Alzheimer’s Disease (AD) market will increase slightly from $3.6 billion in 2012 to $3.8 billion…

FinancialGlobalMarkets & MarketingNeurologicalPharmaceuticalResearch

Renal cell cancer market to rapidly decline from 2019

Renal cell cancer market to rapidly decline from 2019

24-12-2013

The renal cell cancer market is expected to peak at a value of $2.7 billion in 2019, before significantly…

AfinitorAvastinBayerFinancialGlaxoSmithKlineInlytaMarkets & MarketingNexavarNorthern EuropeNovartisOncologyPfizerPharmaceuticalRocheSutentToriselUSAVotrient

What will 2014 hold for pharma?

What will 2014 hold for pharma?

20-12-2013

We take a look at key trends for 2014.

FinancialGlobalMarkets & MarketingPharmaceutical

Novo Nordisk and Sanofi best positioned in diabetes market, says Morningstar

Novo Nordisk and Sanofi best positioned in diabetes market, says Morningstar

10-12-2013

Demographics favor the continued strong growth in the diabetes care market, and independent investment…

DiabetesEli LillyFinancialMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Chronic kidney disease market to witness slight decline by 2017

Chronic kidney disease market to witness slight decline by 2017

12-11-2013

The value of the chronic kidney disease market could drop 2.5% between 2012 and 2017 due to the loss…

EuropeFinancialGenzymeMarkets & MarketingNephrology and HepatologyPharmaceuticalRenagelRenvelaUSAZemplar Capsules

Johnson & Johnson to pay over $2.2 billion to settle DoJ probe

Johnson & Johnson to pay over $2.2 billion to settle DoJ probe

05-11-2013

Global health care giant Johnson & Johnson and its subsidiaries will pay more than $2.2 billion to resolve…

FinancialInvegaJanssenJohnson & JohnsonLegalMarkets & MarketingNatrecorNorth AmericaPharmaceuticalRisperdalScios

Theravance and GSK launch Breo Ellipta in USA

Theravance and GSK launch Breo Ellipta in USA

30-10-2013

GlaxoSmithKline and US partner Theravance today announced that Breo Ellipta for COPD is available to…

Breo ElliptaFinancialGlaxoSmithKlineMarkets & MarketingNorth AmericaPharmaceuticalRespiratory and PulmonaryTheravance

1 to 25 of 96 results

Back to top